Accès gratuit
Numéro
Med Sci (Paris)
Volume 28, Numéro 8-9, Août–Septembre 2012
Page(s) 692 - 695
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2012288006
Publié en ligne 22 août 2012
  1. Richmond TD, Chohan M, Barber DL. Turning cells red: signal transduction mediated by erythropoietin. Trends Cell Biol 2005 ; 15 : 146–155. [CrossRef] [PubMed]
  2. Koury MJ, Bondurant MC. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 1990 ; 248 : 378–381. [CrossRef] [PubMed]
  3. Kelley LL, Koury MJ, Bondurant MC, et al. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production. Blood 1993 ; 82 : 2340–2352. [PubMed]
  4. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004 ; 5 : 343–354. [CrossRef] [PubMed]
  5. Levy JE, Jin O, Fujiwara Y, et al. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat Genet 1999 ; 21 : 396–399. [CrossRef] [PubMed]
  6. Daniels TR, Delgado T, Rodriguez JA, et al. The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer. Clin Immunol 2006 ; 121 : 144–158. [CrossRef] [PubMed]
  7. Schmidt PJ, Toran PT, Giannetti AM, et al. The transferrin receptor modulates Hfe-dependent regulation of hepcidin expression. Cell Metab 2008 ; 7 : 205–214. [CrossRef] [PubMed]
  8. Radoshitzky SR, Abraham J, Spiropoulou CF, et al. Transferrin receptor 1 is a cellular receptor for New World haemorrhagic fever arenaviruses. Nature 2007 ; 446 : 92–96. [CrossRef] [PubMed]
  9. Li L, Fang CJ, Ryan JC, et al. Binding and uptake of H-ferritin are mediated by human transferrin receptor-1. Proc Natl Acad Sci USA 2010 ; 107 : 3505–3510. [CrossRef]
  10. Moura IC, Centelles MN, Arcos-Fajardo M, et al. Identification of the transferrin receptor as a novel immunoglobulin (Ig)A1 receptor and its enhanced expression on mesangial cells in IgA nephropathy. J Exp Med 2001 ; 194 : 417–425. [CrossRef] [PubMed]
  11. Moura IC, Arcos-Fajardo M, Sadaka C, et al. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol 2004 ; 15 : 622–634. [CrossRef] [PubMed]
  12. Matysiak-Budnik T, Moura IC, Arcos-Fajardo M, et al. Secretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease. J Exp Med 2008 ; 205 : 143–154. [CrossRef] [PubMed]
  13. Duchez S, Amin R, Cogne N, et al. Premature replacement of mu with alpha immunoglobulin chains impairs lymphopoiesis and mucosal homing but promotes plasma cell maturation. Proc Natl Acad Sci USA 2010 ; 107 : 3064–3069. [CrossRef]
  14. Rizzo JD, Brouwers M, Hurley P, et al. American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Clin Oncol 28 : 4996–5010. [CrossRef] [PubMed]
  15. Bohlius J, Schmidlin K, Brillant C, et al. Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials. Lancet 2009 ; 373 : 1532–1542. [CrossRef] [PubMed]
  16. Leyland-Jones B, Semiglazov V, Pawlicki M, et al. Maintaining normal hemoglobin levels with epoetin alfa in mainly nonanemic patients with metastatic breast cancer receiving first-line chemotherapy: a survival study. J Clin Oncol 2005 ; 23 : 5960–5972. [CrossRef] [PubMed]
  17. Liang K, Esteva FJ, Albarracin C, et al. Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation. Cancer Cell 2010 ; 18 : 423–435. [CrossRef] [PubMed]
  18. Pasquier B, Launay P, Kanamaru Y, et al. Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. Immunity 2005 ; 22 : 31–42. [PubMed]
  19. Nicolas G, Vaulont S. Le mécanisme d’action de l’hepcidine déchiffré. Med Sci (Paris) 2005 ; 21 : 7–9. [CrossRef] [EDP Sciences] [PubMed]
  20. Coulon S, Dussiot M, Grapton D, et al. Polymeric IgA1 controls erythroblast proliferation and accelerates erythropoiesis recovery in anemia. Nat Med 2011 ; 17 : 1456–1465. [CrossRef] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.